OM — Outset Medical Income Statement
0.000.00%
Last trade - 00:00- $205.22m
- $243.91m
- $113.69m
- 41
- 19
- 61
- 35
Annual income statement for Outset Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 49.9 | 103 | 115 | 130 | 114 |
| Cost of Revenue | |||||
| Gross Profit | -13 | 7.61 | 17.8 | 29 | 38.6 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 169 | 233 | 278 | 300 | 227 |
| Operating Profit | -119 | -131 | -162 | -170 | -113 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -121 | -132 | -163 | -172 | -127 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -121 | -132 | -163 | -173 | -128 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -121 | -132 | -163 | -173 | -128 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -79.3 | -132 | -163 | -173 | -128 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.82 | -2.89 | -3.37 | -3.48 | -2.39 |